Mitochondrial GSNOR Alleviates Cardiac Dysfunction via ANT1 Denitrosylation
Circulation Research · 21.07.2023 · 133 (3) · 220-236
DOI: 10.1161/circresaha.123.322654 ↗Kurz gefasst
Fachartikel in der Zeitschrift Circulation Research, erschienen am 21.07.2023. Verfasst von Xin Tang und 23 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Cardiovascular and Cerebrovascular Medicine, Key Laboratory of Targeted Intervention of Cardiovascular Disease, Collaborative Innov…. Hauptthemen laut MEDLINE: Heart Failure, Ventricular Remodeling. Die Arbeit wurde bisher 62-mal zitiert (Crossref) und nennt 62 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: The cardiac-protective role of GSNOR (S-nitrosoglutathione reductase) in the cytoplasm, as a denitrosylase enzyme of S-nitrosylation, has been reported in cardiac remodeling, but whether GSNOR is localized in other organelles and exerts novel effects remains unknown. We aimed to elucidate the effects of mitochondrial GSNOR, a novel subcellular localization of GSNOR, on cardiac remodeling and heart failure (HF). METHODS: GSNOR subcellular localization was observed by cellular fractionation assay, immunofluorescent staining, and colloidal gold particle staining. Overexpression of GSNOR in mitochondria was achieved by mitochondria-targeting sequence-directed adeno-associated virus 9. Cardiac-specific knockout of GSNOR mice was used to examine the role of GSNOR in HF. S-nitrosylation sites of ANT1 (adenine nucleotide translocase 1) were identified using biotin-switch and liquid chromatography-tandem mass spectrometry. RESULTS: GSNOR expression was suppressed in cardiac tissues of patients with HF. Consistently, cardiac-specific knockout mice showed aggravated pathological remodeling induced by transverse aortic constriction. We found that GSNOR is also localized in mitochondria. In the angiotensin II–induced hypertrophic cardiomyocytes, mitochondrial GSNOR levels significantly decreased along with mitochondrial functional impairment. Restoration of mitochondrial GSNOR levels in cardiac-specific knockout mice significantly improved mitochondrial function and cardiac performance in transverse aortic constriction–induced HF mice. Mechanistically, we identified ANT1 as a direct target of GSNOR. A decrease in mitochondrial GSNOR under HF leads to an elevation of S-nitrosylation ANT1 at cysteine 160 (C160). In accordance with these findings, overexpression of either mitochondrial GSNOR or ANT1 C160A, non-nitrosylated mutant, significantly improved mitochondrial function, maintained the mitochondrial membrane potential, and upregulated mitophagy. CONCLUSIONS: We identified a novel species of GSNOR localized in mitochondria and found mitochondrial GSNOR plays an essential role in maintaining mitochondrial homeostasis through ANT1 denitrosylation, which provides a potential novel therapeutic target for HF.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Cardiovascular and Cerebrovascular Medicine, Key Laboratory of Targeted Intervention of Cardiovascular Disease, Collaborative Innovation Center for Cardiovascular Disease Translational Medicine, The Af…
- Department of Thoracic and Cardiovascular Surgery, the Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University, Institute of Cardio…
- State Key Laboratory of Frigid Zone Cardiovascular Diseases (SKLFZCD), Department of Pharmacology (State-Province Key Laboratories of Biomedicine-Pharmaceutics of China), College of Pharmacy, Key Laboratory of Cardiovas…
- Department of Cardiology, Nanjing First Hospital (S.C.), Nanjing Medical University, Jiangsu, China.
- Department of Cardiology (L.W.), First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
- State Key Laboratory of Reproductive Medicine, Institute of Toxicology, School of Public Health (A.G.), Nanjing Medical University, Jiangsu, China.
ORCID-Profile: Jieqiong Liu, Lulu Hu, Yuanqing Gao, Hongshan Chen, Zhiren Zhang, Liansheng Wang, Feng Chen, Jun Pu, Bo Yu, Liping Xie, Zhengrong Huang, Yi Han, Yong Ji
Zitieren
APA
Tang, X., Zhao, S., Liu, J., Liu, X., Sha, X., Huang, C., Hu, L., Sun, S., Gao, Y., Chen, H., Zhang, Z., Wang, D., Gu, Y., Chen, S., Wang, L., Gu, A., Chen, F., Pu, J., Chen, X., …, & Ji, Y. (2023). Mitochondrial GSNOR Alleviates Cardiac Dysfunction via ANT1 Denitrosylation. Circulation Research, 133(3), 220-236. https://doi.org/10.1161/circresaha.123.322654
Vancouver
Tang X, Zhao S, Liu J, Liu X, Sha X, Huang C, et al. Mitochondrial GSNOR Alleviates Cardiac Dysfunction via ANT1 Denitrosylation. Circulation Research. 2023;133(3):220-236. doi:10.1161/circresaha.123.322654
BibTeX
@article{Tang2023,
author = {Tang, Xin and Zhao, Shuang and Liu, Jieqiong and Liu, Xiameng and Sha, Xinqi and Huang, Changgao and Hu, Lulu and Sun, Shixiu and Gao, Yuanqing and Chen, Hongshan and Zhang, Zhiren and Wang, Dongjin and Gu, Yuexi and Chen, Shaoliang and Wang, Liansheng and Gu, Aihua and Chen, Feng and Pu, Jun and Chen, Xin and Yu, Bo and Xie, Liping and Huang, Zhengrong and Han, Yi and Ji, Yong},
title = {Mitochondrial GSNOR Alleviates Cardiac Dysfunction via ANT1 Denitrosylation},
journal = {Circulation Research},
year = {2023},
volume = {133},
number = {3},
pages = {220--236},
doi = {10.1161/circresaha.123.322654}
}
EUVIMED